PubMed · 11808176
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
R Kadoya. 2001. [Rubella].. https://pubmed.ncbi.nlm.nih.gov/11808176/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
BACKGROUND: Primary dilated cardiomyopathy is rare in women of childbearing age. The expected increase in intravascular volume and cardiac output during pregnancy is poorly tolerated by patients with primary dilated cardiomyopathy and may result in cardiac failure. CASE: A primigravid teenager with a history of primary dilated cardiomyopathy developed severe acute cardiac failure at 20 weeks' gestation. She required ventilation and was treated with inotropes and nitroglycerin. After counseling, she underwent termination of pregnancy using misoprostol. She recovered and was discharged 5 days after delivery. CONCLUSION: Pregnancy in patients with primary dilated cardiomyopathy can be extremely hazardous, resulting in cardiac failure and even death. A multidisciplinary approach and consideration of termination of pregnancy may be required in management of such patients.
Twin pregnancy consisting of complete hydatidiform mole (H-mole) and a coexisting fetus occurs with an estimated incidence of 1 per 22,000-100,000 pregnancies. The incidence of this unusual twin pregnancy with complete H-mole and a coexisting fetus after in vitro fertilization and embryo transfer (IVF-ET) is not thought to be greater than that of general population. We present an unusual twin pregnancy with complete H-mole and a coexisting fetus that occurred following IVF-ET, which was terminated at 21 weeks of gestation and developed into nonmetastatic gestational trophoblastic tumor.